期刊
MEDCHEMCOMM
卷 9, 期 6, 页码 963-968出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8md00068a
关键词
-
资金
- TAKTIC Translational Kinase Tumour Inhibitor discovery Consortium FP7-SME-2012 grant [315746]
NF-kappa B-inducing kinase (NIK), an oncogenic drug target that is associated with various cancers, is a central signalling component of the non-canonical pathway. A blind screening process, which established that amino pyrazole related scaffolds have an effect on IKKbeta, led to a hit-to-lead optimization process that identified the aminopyrazole 3a as a low M selective NIK inhibitor. Compound 3a effectively inhibited the NIK-dependent activation of the NF-kappa B pathway in tumour cells, confirming its selective inhibitory profile.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据